ISORAY INC (ISR)       0.3254  +0.03 (+8.72%)

0.3254  +0.03 (+8.72%)

US46489V1044 - Common Stock - After market: 0.3301 +0 (+1.44%)

ISORAY INC0.3254

NYSEARCA:ISR (1/30/2023, 7:04:00 PM)+0.03 (+8.72%)

After market: 0.3301 +0 (+1.44%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 09-28 2022-09-28/amc Earnings (Next) N/A N/A
Ins Owners 0.27% Inst Owners 11.29%
Market Cap 46.24M Shares 142.11M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 83.33
IPO 05-31 2002-05-31

Stock Screener Links

Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ISR Daily chart

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company is headquartered in Richland, Washington and currently employs 66 full-time employees. The company went IPO on 2002-05-31. The Company, through its subsidiary, Isoray Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The firm is engaged in production and sale of Cesium-131 brachytherapy seeds. Brachytherapy seeds are small devices that deliver a personalized targeted therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cesium-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer. The Company’s Cesium-131 is classified as a Class II device.

Company Info

ISORAY INC

350 Hills Street, Suite 106

Richland WASHINGTON 99354

P: 15093751202.0

CEO: Lori A. Woods

Employees: 66

Website: https://isoray.com/

ISR News

News Image21 hours ago - Isoray, Inc.Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders

Stockholders Approve Proposal One Clearing Way for Consummation of Merger...

News Image19 days ago - Isoray, Inc.Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023

RICHLAND, Wash., Jan. 12, 2023 (GLOBE NEWSWIRE) --  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy...

News Image2 months ago - Isoray, Inc.AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023

RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy...

News Image2 months ago - Isoray, Inc.Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2022

RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy...

News Image3 months ago - Kahn Swick & Foti, LLCISORAY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Isoray, Inc - ISRNews Image3 months ago - Isoray, Inc.Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

RICHLAND, Wash., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy...

ISR Twits

Here you can normally see the latest stock twits on ISR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example